PRIMARY STUDY

Tetrahydrocannabinol vape-associated cannabis arteritis in a patient with minimal tobacco exposure

Key Findings:  This case report outlines a 31-year-old man who developed claudication coinciding with his vaping high-potency tetrahydrocannabinol. This condition is normally seen with concurrent tobacco use, but this case suggests cannabis may also be a causative agent of thromboangiitis obliterans-like arteritis.

Type of Study:  Meta-analysis

Study Sample Size:  1

Study Result:  Negative

Research Location(s):  United States

Year of Pub:  2024


Cannabinoids Studied:  Tetrahydrocannabinol (THC)

Phytocannabinoid Source:  Not Applicable

Chemotype:  Chemotype I




Citation:  Colling M, Souri Y, Reifsnyder T. Tetrahydrocannabinol vape-associated cannabis arteritis in a patient with minimal tobacco exposure. J Vasc Surg Cases Innov Tech. 2024 Nov 8;11(1):101673. doi: 10.1016/j.jvscit.2024.101673. PMID: 39691796; PMCID: PMC11650286.